Sa1540 Cost Minimization Analysis of Onsite Cytopathologist (cyp) Evaluation During EUS FNA of Solid Pancreatic Lesions (SPL)

Availability of onsite CyP evaluation during EUS FNA of SPL can increase diagnostic yield of malignancy with a significantly lower number of EUS-FNA passes. However, studies on clinical impact of onsite CyP have reported conflicting results and considerable additional resources are required to have onsite CyP available at a facility.